Clinical trial Recruiting at 1 site Interventional Ages 19 to 70

Pharmacopuncture vs. physical therapy for chronic lumbar radiculopathy

Official title: Effectiveness and Safety of Pharmacopuncture Therapy for Chronic Lumbar Radiculopathy: A Multicenter, Pragmatic, Randomized, Comparative Clinical Trial

Run by Jaseng Medical Foundation · NCT07832318 · Data updated 2026-11-12

This pragmatic trial tests whether pharmacopuncture can help people with chronic lumbar radiculopathy as well as or better than physical therapy.

Quick facts

Study typeInterventional
Ages19 Years to 70 Years
SexAll
Enrollment92 (estimated)
SponsorJaseng Medical Foundation
Academic / other
Locations4 sites (Bucheon-si, Gyeonggi-do and 3 other locations)
StatusRecruiting
StartedAugust 22, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedSeptember 21, 2026
Trial IDNCT07832318 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 19 to 70 with at least 3 months of persistent sciatica and a leg pain NRS of 4 or higher, suitable for either pharmacopuncture or physical therapy.

Probably not a fit

Patients with serious spinal or neurological conditions or pain from non-spinal sources may not benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, pragmatic randomized trial compares pharmacopuncture to physical therapy in adults with chronic lumbar radiculopathy. Ninety-two participants will be randomly assigned to 46 receive pharmacopuncture and 46 receive physical therapy, with treatments guided by each patient’s clinical condition. The study emphasizes real-world practice by not fixing the exact treatment methods in advance and by documenting all interventions in medical records for analysis. Primary goals are to assess relative effectiveness and safety in managing leg pain and related symptoms in a typical clinical setting. Recruitment occurs at four traditional Korean medicine hospitals in Korea.

Why it matters

Potential benefit: If pharmacopuncture proves effective, patients may have an additional therapeutic option for managing chronic lumbar radiculopathy symptoms.

How similar studies have gone: Previous pragmatic studies in integrative medicine have shown mixed results; this trial investigates a similar approach in a real-world setting for lumbar radiculopathy.

Who can join: the full rules

Show full inclusion / exclusion criteria
1\. Inclusion Criteria:

1. Persistent sciatica symptoms lasting for more than 3 months.
2. Presence of at least one of the following signs in one or both lower extremities: Muscle weakness / Dermatomal sensory disturbance (hypoesthesia, dysesthesia, tingling, or pain) / Decreased reflexes / Radiating pain aggravated by the Straight Leg Raising (SLR) test
3. Numeric Rating Scale (NRS) score of 4 or higher for leg pain.
4. Aged between 19 and 70 years.
5. Provided written informed consent to participate in the clinical trial.

2\. Exclusion Criteria:

1. Diagnosed with serious conditions that may cause lower limb radiating pain (e.g., spinal metastasis of cancer, acute vertebral fracture, or dislocation).
2. Presence of progressive neurological deficits or severe neurological symptoms.
3. Pain originating from non-spinal soft tissue disorders (e.g., tumors, fibromyalgia, rheumatoid arthritis, gout).
4. Presence of chronic diseases that may interfere with treatment outcomes or interpretation (e.g., stroke, myocardial infarction, renal disease, diabetic neuropathy, dementia, epilepsy).
5. Current use of steroids, immunosuppressants, psychiatric medications, or other drugs that may affect study outcomes.
6. Inappropriate or unsafe conditions for pharmacopuncture, including bleeding disorders, anticoagulant therapy, or severe diabetes with high infection risk.
7. Use of analgesic medications such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or receipt of acupuncture, pharmacopuncture, or physical therapy within the past 7 days.
8. Pregnant, planning to become pregnant, or currently breastfeeding.
9. Within 3 months post-lumbar spine surgery.
10. Participation in another clinical trial within the past month, or planned participation in another clinical trial (including follow-up period) within 6 months from the screening date.
11. Difficulty in completing the informed consent process.
12. Any other condition that the investigator deems inappropriate for participation in the clinical trial.

Where it's running

  • Kyung Hee University Korean Medicine Hospital at Gangdong
    Seoul, Seoul, South Korea
    Recruiting
  • Bucheon Jaseng Hospital of Korean Medicine
    Bucheon-si, Gyeonggi-do, South Korea
    Completed
  • Kyung Hee University Korean Medicine Hospital at Gangdong
    Seongnam-si, Gyeonggi-do, South Korea
    Completed
  • Jaseng Hospital of Korean Medicine
    Seoul, Seoul, South Korea
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.